Biochemistry Expert Witnesses: 3

Dr. James C. Norris, Ph.D., DABT, EURT is an Expert Witness in Toxicology and Pharmacology. He has Litigation and Arbitration experience in the United States, United Kingdom and Hong Kong. Dr. Norris has given testimony to government agencies, has acted as a consultant for the media (BBC) and is an Industrial Site Crisis Team Member. He is avaliable for both Plaintiff and Defense.

Areas Of Expertise:

• Carcinogenicity and Chemicals
• Combustion or Fire Toxicolog
• General and Inhalation Toxicology
• Pesticides, and Pharmaceuticals (pharmacology)

Professional Affiliations:

• American Association of Pharmaceutical Scientists
• British Toxicology Society
• Society of Toxicology
• Editorial Boards of Inhalation Toxicology and Journal of Fire Sciences

Gary D. Fletcher, PhD,  is the Founder and Principal Consultant at RnDDx Solutions LLC, a consulting firm founded in 2015, focused on Industrial Mechanical Engineering and Biomedical Engineering and Research and Product Development.  In his 30 years of experience, he has been co-inventor on 23 patents for devices and methods in blood collection and processing.

Litigation Support - Dr. Fletcher has subject matter expertise in Medical Device Mechanical Engineering and subject matter expertise in Medical Devices for Blood Collection and Blood Sample processing for diagnostics and therapeutics. He serves as an expert witness in patent infringement cases involving medical device and diagnostic biomedical engineering, blood collection, separation, fluidic preparation, and cell therapy preparation devices.

Dr. Fletcher offers patent litigation services to law firms and lawyers supporting medical device and diagnostic industry clients, who need physical science and mechanical and biomedical engineering expertise for District Court, PTAB, and International Trade Commision patent cases. As an industry consultant, his ideal clients are R&D, product development, and innovation leaders in startup, emerging, and established medical device and diagnostic companies, who face product development and competitive challenges.

Areas of Expertise:

Dr. Fletcher is an entrepreneurial executive with expanding R&D roles in business, technology, and new product development leadership and execution, building and guiding teams in both Fortune 500 and startup companies. With a PhD in physics from Yale, he has a proven record of leadership in creating innovative new businesses and products in healthcare, medical devices, diagnostics, life, materials, and optical sciences.

J. Paul Robinson, PhD, is a Distinguished Professor of Cytometry in the College of Veterinary Medicine and a professor of Biomedical Engineering in the Weldon School of Biomedical Engineering at Purdue University. Dr. Robinson received his PhD in Immunopathology from the University of New South Wales, Sydney, Australia. He completed a postdoctoral fellowship at the University of Michigan Medical School and is currently the director of the Purdue University Cytometry Laboratories at Purdue University.

Litigation Support - Dr. Robinson provides frequent Patent Infringement expert witness services in the field of Cytometry, the quantitative analysis of cells and cell systems, most commonly used to evaluate bone marrow, peripheral blood, and other fluids in the body. His services are available to attorneys representing plaintiff and defendant and include record review, thorough reporting, depositions, and trial testimony as needed.

Areas of Expertise:

Backround Experience - Dr. Robinson's research area has been focused on reactive oxygen species primarily in neutrophils and cell lines such as HL-60 cells where he has developed high throughput functional approaches to cell analysis related to mitochondrial function as a measure of drug toxicity. He is also interested in automated diagnostics focused on blood cell phenotypic analysis using data mining processes integrated with real-time multiparameter analysis. In addition he is engaged in developing translational tools for better diagnostics for cervical cancer.

Over the past several years, his group has expanded their interest in bioengineering with hardware and software groups developing innovative technologies such as spectral flow cytometry (USPatent#7280204 - currently commercialized by two companies), optical tools for quantitative fluorescence measurement and advanced classification approaches for clinical diagnostics as well as bacterial classification using elastic scattering of laser light.

Dr. Robinson is an active researcher with over 200 peer reviewed publications, 35 book chapters, and has edited 10 books. He has given over 150 international lectures, 400 conference presentations, and taught advanced courses in over a dozen countries.